Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis.

Thom, Howard; Cheng, Vincent; Keeney, Edna; Neary, Maureen P; Eccleston, Anthony; Zang, Chuanbo; Cappelleri, Joseph C; Cha, Amy; Thyssen, Jacob P

Thom, Howard; Cheng, Vincent; Keeney, Edna; Neary, Maureen P; Eccleston, Anthony; Zang, Chuanbo; Cappelleri, Joseph C; Cha, Amy; Thyssen, Jacob P.

Afiliación

Thom H; Bristol Medical School, University of Bristol, Bristol, UK. howard.thom@bristol.ac.uk.
Cheng V; Clifton Insight, Bristol, UK. howard.thom@bristol.ac.uk.
Keeney E; Bristol Medical School, University of Bristol, Bristol, UK.
Neary MP; Clifton Insight, Bristol, UK.
Eccleston A; Bristol Medical School, University of Bristol, Bristol, UK.
Zang C; Clifton Insight, Bristol, UK.
Cappelleri JC; Pfizer Inc., Collegeville, PA, USA.
Cha A; Pfizer Ltd., London, UK.
Thyssen JP; Pfizer Inc., Collegeville, PA, USA.

Dermatol Ther (Heidelb) ; 12(1): 185-194, 2022 Jan.

Article en En | MEDLINE | ID: mdl-34877623

Palabras clave

Atopic dermatitis; Calcineurin inhibitors; Crisaborole; Matching-adjusted indirect comparison; Topical calcineurin inhibitors; Topical corticosteroids

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Idioma: En Revista: Dermatol Ther (Heidelb) Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google